Impact BioMedical Inc.
IBO
$0.58
$0.00-0.46%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.47M | -25.01M | -24.71M | 1.17M | -4.25M |
| Total Depreciation and Amortization | 7.00K | 6.00K | 7.00K | 6.00K | 5.00K |
| Total Amortization of Deferred Charges | 1.12M | 1.12M | 1.11M | 1.11M | 1.11M |
| Total Other Non-Cash Items | 33.96M | 20.89M | 20.79M | -5.22M | 439.00K |
| Change in Net Operating Assets | -534.00K | -603.00K | -608.00K | 352.00K | 717.00K |
| Cash from Operations | -3.92M | -3.61M | -3.41M | -2.59M | -1.97M |
| Capital Expenditure | -- | -- | -- | 0.00 | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.00K | 3.00K | 2.00K | 3.00K | 2.00K |
| Cash from Investing | 2.00K | 3.00K | 2.00K | 3.00K | 1.00K |
| Total Debt Issued | 811.00K | 1.20M | 1.68M | 1.32M | 1.97M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.73M | 3.73M | 3.73M | 3.73M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.54M | 4.92M | 5.40M | 5.05M | 1.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 622.00K | 1.32M | 2.00M | 2.47M | -1.00K |